BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28571972)

  • 21. Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series.
    Lachance N; Guiral S; Huang Z; Leclerc JP; Li CS; Oballa RM; Ramtohul YK; Wang H; Wu J; Zhang L
    Bioorg Med Chem Lett; 2012 Jan; 22(1):623-7. PubMed ID: 22101133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series.
    Lachance N; Gareau Y; Guiral S; Huang Z; Isabel E; Leclerc JP; Léger S; Martins E; Nadeau C; Oballa RM; Ouellet SG; Powell DA; Ramtohul YK; Tranmer GK; Trinh T; Wang H; Zhang L
    Bioorg Med Chem Lett; 2012 Jan; 22(2):980-4. PubMed ID: 22209206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition.
    Ono A; Sano O; Kazetani KI; Muraki T; Imamura K; Sumi H; Matsui J; Iwata H
    PLoS One; 2017; 12(7):e0181243. PubMed ID: 28704514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors.
    Sun S; Zhang Z; Pokrovskaia N; Chowdhury S; Jia Q; Chang E; Khakh K; Kwan R; McLaren DG; Radomski CC; Ratkay LG; Fu J; Dales NA; Winther MD
    Bioorg Med Chem; 2015 Feb; 23(3):455-65. PubMed ID: 25555732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).
    Voss MD; Zoller G; Matter H; Herling AW; Biemer-Daub G; Pfenninger A; Haag-Diergarten S; Keil S; Kohlmann M; Schmidts HL
    Eur J Pharmacol; 2013 May; 707(1-3):140-6. PubMed ID: 23524088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Aryl benzimidazoles: human SCD1-specific stearoyl coenzyme-A desaturase inhibitors.
    Powell DA; Ramtohul Y; Lebrun ME; Oballa R; Bhat S; Falgueyret JP; Guiral S; Huang Z; Skorey K; Tawa P; Zhang L
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6366-9. PubMed ID: 20933412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.
    Sun S; Zhang Z; Kodumuru V; Pokrovskaia N; Fonarev J; Jia Q; Leung PY; Tran J; Ratkay LG; McLaren DG; Radomski C; Chowdhury S; Fu J; Hubbard B; Winther MD; Dales NA
    Bioorg Med Chem Lett; 2014 Jan; 24(2):520-5. PubMed ID: 24374272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors.
    Uto Y
    Chem Phys Lipids; 2016 May; 197():3-12. PubMed ID: 26344107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects.
    Sun S; Zhang Z; Raina V; Pokrovskaia N; Hou D; Namdari R; Khakh K; Ratkay LG; McLaren DG; Mork M; Fu J; Ferreira S; Hubbard B; Winther MD; Dales N
    Bioorg Med Chem Lett; 2014 Jan; 24(2):526-31. PubMed ID: 24370012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based virtual screening of natural products as potential stearoyl-coenzyme a desaturase 1 (SCD1) inhibitors.
    Huang Y; Wang H; Wang H; Wen R; Geng X; Huang T; Shi J; Wang X; Wang J
    Comput Biol Chem; 2020 Jun; 86():107263. PubMed ID: 32315834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stearoyl-CoA desaturase inhibitors: update on patented compounds.
    Liu G
    Expert Opin Ther Pat; 2009 Sep; 19(9):1169-91. PubMed ID: 19691439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
    Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
    Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy.
    Powell DA; Black WC; Bleasby K; Chan CC; Deschenes D; Gagnon M; Gordon R; Guay J; Guiral S; Hafey MJ; Huang Z; Isabel E; Leblanc Y; Styhler A; Xu LJ; Zhang L; Oballa RM
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7281-6. PubMed ID: 22047692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors.
    Koltun DO; Parkhill EQ; Vasilevich NI; Glushkov AI; Zilbershtein TM; Ivanov AV; Cole AG; Henderson I; Zautke NA; Brunn SA; Mollova N; Leung K; Chisholm JW; Zablocki J
    Bioorg Med Chem Lett; 2009 Apr; 19(7):2048-52. PubMed ID: 19249203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
    Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
    Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
    Dillon R; Greig MJ; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput scintillation proximity assay for stearoyl-CoA desaturase-1.
    Tawa P; Falgueyret JP; Guiral S; Isabel E; Powell DA; Zuck P; Skorey K
    J Biomol Screen; 2011 Jun; 16(5):506-17. PubMed ID: 21406617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in stearoyl-CoA desaturase 1 inhibitors for dyslipidemia and obesity.
    Liu G
    Curr Top Med Chem; 2010; 10(4):419-33. PubMed ID: 20180759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of human stearoyl-coenzyme A desaturase in complex with substrate.
    Wang H; Klein MG; Zou H; Lane W; Snell G; Levin I; Li K; Sang BC
    Nat Struct Mol Biol; 2015 Jul; 22(7):581-5. PubMed ID: 26098317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.